The Anticancer Drug Market is experiencing robust growth as oncology therapies evolve toward precision medicine, targeted treatments, and innovative delivery mechanisms. Valued at US$ 166,669.56 million in 2024, the market is projected to expand at a CAGR of 9.5% from 2025 to 2032. Rising cancer prevalence, advancements in molecular-targeted therapies, and an increasing focus on personalized...